MS Flashcards

(35 cards)

1
Q

What is MS?

A
  • The most common primary demyelinating disease (primary – idiopathic, presumably autoimmune) of CNS
  • Lesions in the white matter
  • Central: oligodendrocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where do demyelinating lesions of MS occur?

A
  • anywhere in the brain and spinal cord
  • constellation of SxS of almost unlimited variety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Optic Nerve

A
  • optic neuritis (pain)
  • progressive loss of visual acuity (painless)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Brainstem

A
  • Diplopia (III, IV, VI)
  • Trigeminal neuralgia (V)
  • Hemifacial spasm (VII)
  • Vertigo, vomiting, nystagmus (VIII)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cerebellum and spinocerebellar path

A
  • Dysarthria, ataxia, abnormal stance and gait
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Spinal Cord

A
  • UMN weakness, spasticity, clonus, Babinski, sensory loss (dorsal columns and anterior lateral system), bowel and bladder dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cerebral Cortex

A
  • intellectual impairment, memory loss, emotional changes, depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Temporal patterns of MS

A
  • Relapsing/remitting (most common)
  • Primary progressive
  • Progressive-relapsing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Relapsing/remitting MS

A
  • Most frequent exacerbations followed by less complete recovery than in benign form
  • Stable: long periods of quiescence
  • Secondary Progressive: fewer remissions with disease progression (more cumulative
    disability)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Primary progressive MS

A
  • Insidious relatively late onset and steady progression of symptoms and disability.
  • More lesions in SC than brain. Different inflammatory cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Progressive- relapsing

A

often diagnosed as primary first, until a relapse occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5 major clinical subtypes of MS

A
  • relapsing remitting
  • primary progressive
  • secondary progressive
  • progressive relapsing
  • clinically isolated syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Relapsing remitting MS characteristics

A

characterized by specific attack
of deficits (relapse stage) with either full or partial recovery
(remitting stage); periods between relapses characterized by lack of disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Primary Progressive MS characteristics

A

characterized by disease
progression and a deterioration of function from onset; may have slight fluctuations but specific attacks do not occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Secondary progressive MS characteristics

A

characterized by an initial
relapsing remitting stage followed by a change to a
progressive course with steady decline in function and
impairments increase with or without specific attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Progressive relapsing MS characteristics

A

characterized by steady
deterioration in disease from onset with occasional attacks-
but time between attacks has continuing progression

17
Q

Clinically isolated syndrome MS characteristics

A

first episode of
inflammatory demyelination in the CNS that could become MS
if additional activity occurs/progression to RRM

18
Q

Risk factors of MS

A
  • female for likely for RRMS
  • equal for PPMS
  • Age 20-30 for RRMS
  • Age 40-50 for PPMS
19
Q

Etiology of MS

A

unknown, likely viral or autoimmune
- May have a precipitating/exacerbating factors- infection,
trauma, pregnancy, stress

20
Q

characteristics of MS overall

A

Demyelinating lesions (plagues) impair neural
transmission, causing nerves to fatigue rapidly

21
Q

Where are lesions common?

A

pyramidal tract, dorsal columns, optic nerve, periventricular areas of cerebrum, cerebellar peduncles

22
Q

Falls in MS

A
  • Progressive MS classification is a significant risk factor
  • use of mobility aid is a significant risk factor
  • consider spasticity, gait disturbances, continence, and fear
23
Q

Fatigue in MS

A
  • Common but a separate entity –> physiologic basis unknown, different fro fatigue experienced by healthy individuals
  • no correlation between severity of fatigue and involvement or severity of fatigue and depression
24
Q

heat sensitivity

A
  • internal sources or external sources
25
Uhthoff Symptom/ Phenomenon
* Increase or presence of neurological symptoms (vision, reflexes, sense) in response to a heating condition. * Range of body temperature that could bring on neurological symptoms (.18 F – 4.14 F)
26
Expanded Disability Status Scale
0: normal neurologic function 1: no disability with only minimal signs 2: minimal disability 3: moderate disability 4: relatively severe disability 5: disability affects full daily activities 6: assistance required to walk and work 7: essentially restricted to WC 8: restricted to bed or WC 9: bedridden and unable to communicate effectively eat/swallow 10: death
27
MSQoL-54
structured, self-report questionnaire that the patient can generally complete with little or no assistance. * It may also be administered by an interviewer. However, patients with visual or upper extremity impairments may need to have the MSQOL-54 administered as an interview.
28
Interventions
Guides by an understanding of the type of MS, location of the plagues, general stages of the disease process, impairments, and functional limitations present
29
View on exercise
* regular exercise is essential to preservation of function in this population by minimizing effects of immobility. * Regarding influence on fatigue and relapse: Exercise therapy can be prescribed in people with MS without harm. Exercise may reduce self-reported fatigue and does not seem to be associated with a significant risk of MS relapse
30
Aerobic Training
* Autonomic regulation issues --> Usually a function of advancing disease * Cardiorespiratory response * It is likely that maximal aerobic capacity in persons with MS is partially influenced by the level of neurological impairment --> Those with greater impairment sustain exercise for a shorter period of time, achieve a lower maximal exercise intensity and a lower oxygen uptake.
31
Precautions
* Strengthening and aerobic training can be safely performed in MS population * Those with minimal impairments have best exercise tolerance and get best benefit * Probably submaximal exercise for stable persons with MS * Many unanswered questions * Prevent over-fatigue and overheating
32
Preventing over-fatigue and overheating
* Aquatic therapy? * Cooling suits * Core body temperature changes throughout the day * Try exercising in the morning * No information on exercise during exacerbations * Don’t want to see increases in neurological signs/ symptoms * Complaints of exercise – related fatigue or Uhthoff symptoms should resolve within an hour following cessation of activity or exposure.
33
Medical Management
* Immunosuppressant drugs- treat acute attacks and shorten episode * Steroids * Interferon drugs- slow disease progression * Symptomatic management- tone reducing, bladder
34
Physical Therapy Goals
* Monitor changes in disease progression, attacks/change in status * Rehab Goals- Focused on restoring function * May receive intense therapy- RRMS- restore function * Ongoing therapy needs- as disease progression occurs may need bouts of therapy to address new problems in function, maintain current level of function, address equipment needs
35
Energy Conservation
* Need to have an idea on level of fatigue and impact of fatigue throughout day * Pacing, optimal scheduling, consideration of weather, use of devices * Psychological support